NCT06840990View on ClinicalTrials.gov

Cross-linked CMC and Silk Proteins in Corneal Re-epithelization

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

June 1, 2024

Conditions
Corneal Epithelial Wound Healing
Interventions
DEVICE

CXC-SP

Standard therapy plus sterile Isotonic ophthalmic solution based on CX-CMC and silk protein, istilled six time a day until complete healing.

DEVICE

CTRL

Standard therapy plus sterile ophtalmic isotonic solution for six time a day until complete healing.

Trial Locations (1)

00184

San Giovanni-Addolorata Hospital, Rome

All Listed Sponsors
collaborator

San Giovanni Addolorata Hospital

OTHER

lead

D&V FARMA srl

INDUSTRY